Characterization of Natural Anti-FVIII Antibodies and the Regulatory Role of the Gut Microbiota in FVIII Immunogenicity
Loading...
Authors
Cormier, Matt
Date
Type
thesis
Language
eng
Keyword
hemophilia A , factor VIII , inhibitors , antibodies , gut microbiota
Alternative Title
Abstract
Patients with hemophilia A bleed spontaneously into the soft tissues and joints due to deficiencies in the coagulation protein Factor VIII (FVIII). One-third of patients develop neutralizing antibodies to standard intravenous replacement therapy, rendering it ineffective. A significant area of research focuses on identifying risk factors associated with the development of FVIII inhibitors and investigating mechanisms of inhibitor pathogenesis. Translating this knowledge into effective strategies or therapeutics to prevent FVIII inhibitor development is highly desired. Here, we have investigated the role of the gut microbiota and natural anti-FVIII antibodies in modulating one’s risk of developing FVIII inhibitors.
The gut microbiota is an expansive network of microorganisms that line the gastrointestinal tract and has been shown to modulate the immune system in mice and humans. We first sought to determine if the gut microbiota plays a role in regulating FVIII inhibitor development by developing a hemophilia A mouse model of antibiotic-induced gut perturbation. Gut perturbation was associated with an enhanced FVIII immune response, decreased short-chain fatty acid (SCFA) production, and an altered transcriptomic environment in the spleen and draining mesenteric lymph nodes.
We further characterized the effects of SCFAs on immune cells and found that only butyrate was able to potently inhibit B cell function ex vivo. Attempts to endogenously increase SCFA production and inhibit FVIII inhibitor formation through a high-fiber diet yielded subtle yet significant changes in the immune response and blood metabolome, revealing complex relationships between gut bacteria and host.
Lastly, natural anti-FVIII antibodies are found in healthy human donors but appear to enhance immunogenicity to the FVIII protein in patients with hemophilia A. We characterized this natural antibody repertoire and found striking differences in the peripheral blood between mice and humans. We discuss how these findings fit into our current understanding of FVIII inhibitor development and shed light on how natural antibodies may modulate peripheral tolerance to the FVIII protein.
Ultimately, this work explores two unknown factors related to the FVIII immune response and highlights the diversity of influences contributing to one’s FVIII inhibitor risk profile.
Description
Citation
Publisher
License
Queen's University's Thesis/Dissertation Non-Exclusive License for Deposit to QSpace and Library and Archives Canada
ProQuest PhD and Master's Theses International Dissemination Agreement
Intellectual Property Guidelines at Queen's University
Copying and Preserving Your Thesis
This publication is made available by the authority of the copyright owner solely for the purpose of private study and research and may not be copied or reproduced except as permitted by the copyright laws without written authority from the copyright owner.
Attribution-NoDerivs 3.0 United States
ProQuest PhD and Master's Theses International Dissemination Agreement
Intellectual Property Guidelines at Queen's University
Copying and Preserving Your Thesis
This publication is made available by the authority of the copyright owner solely for the purpose of private study and research and may not be copied or reproduced except as permitted by the copyright laws without written authority from the copyright owner.
Attribution-NoDerivs 3.0 United States